As of 2025-12-15, the Relative Valuation of Landos Biopharma Inc (LABP) is (103.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -553.5%.
The range of the Relative Valuation is (82.07) - (109.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 13.9x | 10.1x |
| Forward P/E multiples | 10.4x - 18.5x | 16.2x |
| Fair Price | (82.07) - (109.80) | (103.98) |
| Upside | -457.9% - -578.8% | -553.5% |
| Date | P/E |